These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28461708)

  • 1. Bayesian inference for intratumour heterogeneity in mutations and copy number variation.
    Lee J; Müller P; Sengupta S; Gulukota K; Ji Y
    J R Stat Soc Ser C Appl Stat; 2016 Aug; 65(4):547-563. PubMed ID: 28461708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A BAYESIAN NONPARAMETRIC MODEL FOR RECONSTRUCTING TUMOR SUBCLONES BASED ON MUTATION PAIRS.
    Sengupta S; Zhou T; Müeller P; Ji Y
    Pac Symp Biocomput; 2016; 21():393-404. PubMed ID: 26776203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SeqClone: sequential Monte Carlo based inference of tumor subclones.
    Ogundijo OE; Wang X
    BMC Bioinformatics; 2019 Jan; 20(1):6. PubMed ID: 30611189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayclone: Bayesian nonparametric inference of tumor subclones using NGS data.
    Sengupta S; Wang J; Lee J; Müller P; Gulukota K; Banerjee A; Ji Y
    Pac Symp Biocomput; 2015; ():467-78. PubMed ID: 25592605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
    Tai AS; Peng CH; Peng SC; Hsieh WP
    PLoS One; 2018; 13(12):e0206579. PubMed ID: 30540749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BiTSC 2: Bayesian inference of tumor clonal tree by joint analysis of single-cell SNV and CNA data.
    Chen Z; Gong F; Wan L; Ma L
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35368055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Intra-Tumor Heterogeneity From Somatic Mutations Without Copy-Neutral Assumption.
    Ogundijo OE; Zhu K; Wang X; Anastassiou D
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2271-2280. PubMed ID: 32070995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAD Bayes for Tumor Heterogeneity - Feature Allocation with Exponential Family Sampling.
    Xu Y; Müller P; Yuan Y; Gulukota K; Ji Y
    J Am Stat Assoc; 2015 Mar; 110(510):503-514. PubMed ID: 26170513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data.
    Fan Y; Xi L; Hughes DS; Zhang J; Zhang J; Futreal PA; Wheeler DA; Wang W
    Genome Biol; 2016 Aug; 17(1):178. PubMed ID: 27557938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MixClone: a mixture model for inferring tumor subclonal populations.
    Li Y; Xie X
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
    Parisi F; Ariyan S; Narayan D; Bacchiocchi A; Hoyt K; Cheng E; Xu F; Li P; Halaban R; Kluger Y
    BMC Genomics; 2011 May; 12():230. PubMed ID: 21569352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAMSE: Bayesian model selection for tumor phylogeny inference among multiple samples.
    Toosi H; Moeini A; Hajirasouliha I
    BMC Bioinformatics; 2019 Jun; 20(Suppl 11):282. PubMed ID: 31167637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy-number analysis and inference of subclonal populations in cancer genomes using Sclust.
    Cun Y; Yang TP; Achter V; Lang U; Peifer M
    Nat Protoc; 2018 Jun; 13(6):1488-1501. PubMed ID: 29844525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific copy number profiling by next-generation DNA sequencing.
    Chen H; Bell JM; Zavala NA; Ji HP; Zhang NR
    Nucleic Acids Res; 2015 Feb; 43(4):e23. PubMed ID: 25477383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data.
    Lönnstedt IM; Caramia F; Li J; Fumagalli D; Salgado R; Rowan A; Salm M; Kanu N; Savas P; Horswell S; Gade S; Loibl S; Neven P; Sotiriou C; Swanton C; Loi S; Speed TP
    Genome Biol; 2014 Oct; 15(9):470. PubMed ID: 25270265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hidden Markov modeling approach for identifying tumor subclones in next-generation sequencing studies.
    Choo-Wosoba H; Albert PS; Zhu B
    Biostatistics; 2022 Jan; 23(1):69-82. PubMed ID: 32282873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pipeline for Reconstructing Somatic Copy Number Alternation's Subclonal Population-Based Next-Generation Sequencing Data.
    Chu Y; Nie C; Wang Y
    Front Genet; 2019; 10():1374. PubMed ID: 32180789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
    Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
    J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.